Literature DB >> 23740811

[18F]-FBEM, a tracer targeting cell-surface protein thiols for cell trafficking imaging.

Simon Lacroix1, Dominique Egrise, Gaetan Van Simaeys, Gilles Doumont, M Monclus, F Sherer, T Herbaux, D Leroy, Serge Goldman.   

Abstract

We used [(18)F]-4-fluorobenzamido-N-ethylamino-maleimide ([(18)F]-FBEM) to radiolabel cells ex vivo for in vivo positron emission tomography (PET) in order to assess cell trafficking in mice. In contrast to commonly used imaging agents, [(18)F]-FBEM forms a covalent bond with thiol groups present on the cells surface. The stability of the probe in aqueous medium was tested at different pH values and cross-experiment showed that thiol-labeling efficiency was retained (at least) up to pH 9. The labeling procedure did not affect significantly the cell viability. To illustrate the procedure, PET images of living mice injected intravenously with labeled T lymphocytes were obtained. They showed the expected cell homing in the spleen that was absent in mice injected with free label.
Copyright © 2013 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23740811     DOI: 10.1002/cmmi.1540

Source DB:  PubMed          Journal:  Contrast Media Mol Imaging        ISSN: 1555-4309            Impact factor:   3.161


  3 in total

1.  Automated radiosynthesis of [18F]FBEM, a sulfhydryl site specific labeling agent for peptides and proteins.

Authors:  Keunpoong Lim; Jim Ropchan; Dale O Kiesewetter; Xiaoyuan Chen; Yiyun Huang
Journal:  Appl Radiat Isot       Date:  2018-07-29       Impact factor: 1.513

Review 2.  Advances in PET Detection of the Antitumor T Cell Response.

Authors:  M N McCracken; R Tavaré; O N Witte; A M Wu
Journal:  Adv Immunol       Date:  2016-04-05       Impact factor: 3.543

3.  18F-FHBG PET-CT Reporter Gene Imaging of Adoptive CIK Cell Transfer Immunotherapy for Breast Cancer in a Mouse Model.

Authors:  Xiaofeng Li; Guotao Yin; Wei Ji; Jianjing Liu; Yufan Zhang; Jian Wang; Xiang Zhu; Lei Zhu; Dong Dai; Wenchao Ma; Wengui Xu
Journal:  Onco Targets Ther       Date:  2020-11-13       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.